Drug application
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 (MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE and 2 more)
Drugs@FDA ANDA 215371 · FRESENIUS KABI USA
Key facts
| Drug name | MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 |
|---|---|
| Active ingredients | MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE, SODIUM CHLORIDE, SODIUM GLUCONATE |
| Application type | ANDA |
| Application number | 215371 |
| Company | FRESENIUS KABI USA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jun 8, 2022 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: